tiprankstipranks
RenovoRx Secures Funds Through Private Placement Offering
Company Announcements

RenovoRx Secures Funds Through Private Placement Offering

RenovoRx (RNXT) has released an update to notify the public and investors about an entry into a material definitive agreement.

Pick the best stocks and maximize your portfolio:

RenovoRX, Inc. completed a private placement offering on January 26, 2024, raising $6,111,695 from 92 accredited investors. The company met the minimum subscription requirement of $5 million and sold over 6 million shares and warrants at a discounted price of $0.99 per share, with an exercise price equal for both shares and warrants. Company-affiliated investors paid $1.22 per share and warrant. This offering was not registered under the Securities Act of 1933 but relied on exemptions provided by Section 4(a)(2) and Rule 506(c) of Regulation D. RenovoRX committed to filing a registration statement for the resale of the shares within 30 days post-offering. Additionally, RenovoRX hired Paulson Investment Company, LLC as a placement agent, paying them commissions and issuing warrants for their services.

For further insights into RNXT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyRenovoRx announces SCRI Oncology partners enrolling patients for trial
TheFlyRenovoRx receives first purchase orders for FDA-cleared RenovoCath
TheFlyRenovoRx announces NHCI is enrolling patients for Phase III TIGeR-PaC trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App